Massachusetts General Hospital

BiographyDr. Yeh is a graduate of Harvard Medical School, and has also received graduate degrees in health policy from the London School of Economics and business administration from Oxford University.  He completed residency at the MGH, cardiology fellowship at the University of California, San Francisco, and interventional cardiology fellowship at the MGH.  Dr. Yeh is a member of the interventional cardiology staff, focusing on coronary interventional procedures and transradial catheterization.  He is an affiliated faculty member of the Mongan Institute for Health Policy.

His research examines real world outcomes and the comparative effectiveness of novel cardiovascular devices and therapies, in collaboration with faculty at the Department of Health Care Policy at Harvard Medical School.  He also serves as Medical Director for Trial Design at the Harvard Clinical Research Institute, where he is involved in the design of clinical trials and post-marketing studies of cardiovascular devices.

Publications

View my most recent publications at PubMed

Selected Publications:

Yeh RW, Chandra M, McCulloch CE, Go AS.  Accounting forthe mortality benefit of drug-eluting stents in percutaneous coronaryintervention: a comparison of methods in a retrospective cohort study.  BMCMedicine. 2011 Jun 24;9(1):78.

Yeh RW, Kennedy K, Spertus JA, Parikh SA, Sakhuja R,Anderson HV, White CJ, Rosenfield KA.  Do post-marketing surveillancestudies represent real world populations:  A comparison of patientcharacteristics and outcomes after carotid artery stenting.  Circulation. 2011 Apr 5;123(13):1384-90.

Longmore RB, Yeh RW, Kennedy KF, Anderson HV, White CJ,Longmore LS, Rosenfield K, Ho KK, Spertus JA.  Clinical referral patternsfor carotid artery stenting versus carotid endarterectomy: results from theCarotid Artery Revascularization and Endarterectomy Registry.  Circulation:Cardiovascular Interventions. 2011 Feb 1;4(1):88-94.

Yeh RW, Sidney S, Sorel M, Chandra M, Selby JV, Go AS.Population trends in the incidence and outcomes of acute myocardial infarction.The New England Journal of Medicine. 2010 June 10;362(23):2155-65.

Yeh RW, Go AS. Rethinking the Epidemiology of MyocardialInfarction: Challenges and Opportunities. Archives of Internal Medicine. 2010May 10;170(9):759-64.

In General for Dec. 16, 2011

In General awards and honors

Widening Geographic Disparities in Hospitalized Heart Attack Incidence and Outcome Rates

February is American Heart Month, and the spotlight is on heart health. Throughout this month, we will be featuring articles including discussions with physicians in the Massachusetts General Heart Center to learn more about the topics surrounding heart disease, the leading cause of death in the U.S. for both men and women.

Cardiology Grand Rounds

Massachusetts General Hospital Cardiology Grand Rounds take place on Wednesdays from 8:00 am to 9:00 am in the O’Keeffe Auditorium of the Blake Building.

Choice to use drug-eluting stents has little relation to patients' probable benefit

A new study finds that the use of drug-eluting stents after angioplasty bears little relationship to patients' predicted risk of restenosis (reblockage) of the treated coronary artery, the situation the devices are designed to prevent.